Newsletter | September 13, 2024

09.13.24 -- Which Top HEOR Trends Will Have The Biggest Impact On Clinical Research?

TRIAL MONITORING

Why Sponsors Should Obsess Over Clinical Trial Oversight

Just in Time GCP Founder and CEO Donna Dorozinsky explores the importance of clinical trial oversight and what to expect for the future of clinical trial oversight.

Optimizing CAGT Post-Trial Long-Term Follow-Up

Uncover how navigating longer study durations presents unique challenges, necessitating efficient data collection methods and flexibility to adapt to evolving patient journeys and regulatory landscapes.

Data Monitoring Committee Services For Robust Oversight, Integrity

Let us build and manage your data monitoring committee or data safety monitoring board, ensuring oversight and the highest standards of data integrity and participant safety throughout your study.

CLINICAL DATA MANAGEMENT & ANALYTICS

Which Top HEOR Trends Will Have The Biggest Impact On Clinical Research?

ISPOR CEO Rob Abbott discusses Health Economics and Outcomes Research (HEOR) trends and how they're impacting clinical trials. 

AI In Data Management: What Does It Do, And How Does It Work?

Explore how AI revolutionizes clinical data management by automating medical coding, data reconciliation, and audit trail reviews, significantly enhancing efficiency and accuracy.

AI In Drug Development: Navigating Emerging Regulatory Expectations

To implement and leverage artificial intelligence and machine learning across the clinical trial lifecycle ethically, sustainably, and effectively, it is critical for developers and regulators to collaborate.

Breaking The Mold: How R Is Revolutionizing CSR Generation

The open-source statistical programming language R is becoming more popular in the life sciences sector for clinical study report submissions due to its cost-effectiveness, inclusivity, and collaboration.

5 Key Takeaways From The FDA's Real-World Evidence Guidance

With our advanced technology and expertise, sponsors can confidently conduct RWE studies that are efficient and aligned with the FDA’s data-driven vision for healthcare.

How FAIR Data Principles Deliver Clinical Success

Prioritize data management that adheres to FAIR principles — findable, accessible, interoperable, and reusable — to gain operational insights that enable quick decisions and ensure participant well-being.

How Historical Data And Controls Improve Clinical Trials

Discover the importance of historical data in clinical trials and the potential benefits it can provide for researchers and healthcare professionals.

Reducing PMC/PMR Study Burdens For Sponsors, Sites, And Patients

VP of Research Oncology, Neal Meropol, MD, shares how a pragmatic approach to postmarketing commitments and postmarketing requirements can reduce the burden of these studies.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Friday edition of the Clinical Leader newsletter, focusing on Clinical Data Management & Analytics and Trial Monitoring. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: